We highly recommend working with @deviationcap. @DusanPerovic has been an incredible partner during Isabl's journey as a start up!
Introducing Deviation Capital.
Era-defining companies are the exception. They break almost every rule of conventional wisdom as they rise, but start the same way. A founder encounters something broken, invents a way forward others couldn't see, and bets everything on bringing it to life.
We launch today as the spinout of Two Sigma Ventures to find, fund, and support these founders, backing technical teams harnessing data and computing to build enduring exceptions.
isabl.io is now providing rapid cancer WGS analysis! Transform raw data into comprehensive sample and cohort reports in under a week. Tailored for solid and hematologic cancers. (1/2)
Get in touch at [email protected].
#WGS #RNAseq #Cancer #PrecisionOncology
Isabl Inc. retweeted
What is the risk conferred by my disease? One of the hardest questions to answer in medicine. A on the development of the International Prognostic Scoring System Molecular in MDS published today bit.ly/3aNEU64
Isabl Inc. retweeted
Ultima Genomics claims $100 full genome sequencing after stealth $600M raise tcrn.ch/3x35WyY | by Devin Coldewey
Isabl Inc. retweeted
MSK Starts Offering Pediatric Cancer Patients Whole-Genome, Transcriptome Sequencing. The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community. ow.ly/Bt89103FVCW
Isabl Inc. retweeted
Impressive turnaround times for cancer whole genome & transcriptome sequencing (cWGTS) - 9 days from start to finish - and application to pediatric & #AYAcancer
From @PapaemmanuilLab and colleagues
nature.com/articles/s41467-0… – at West University Place, TX
Isabl Inc. retweeted
Very happy to see this kind of technology coming to market for kids with cancer
techcrunch.com/2022/05/18/is…
Isabl Inc. retweeted
Could an experimental approach to genetic testing in children and young adults with cancer match them with better treatment options? Drs. Andrew Kung and @PapaemmanuilLab, whose findings published in @Nature, think so. bit.ly/3Mu7I1i
Isabl Inc. retweeted
Isabl's rapid whole-genome analysis opens the playbook for cancer treatment tcrn.ch/3Mr9AI9 | by Devin Coldewey
Isabl Inc. retweeted
Congrats @PapaemmanuilLab, @jsmedmar, Andrew, and team @isabl_io on the new milestone!
The FDA grants Isabl (YC W20) Breakthrough Device designation to improve the diagnosis of pediatric cancer patients: techcrunch.com/2022/05/18/is…
Isabl Inc. retweeted
Congratulations to @WCMEnglanderIPM's Director of Research Pathology Dr. Juan Miguel Mosquera, a Member of the @WCMCPathology team, on his @TheUSCAP-accepted abstract with #EIPM's Dr. Majd Al Assad and colleagues, with @Isabl_io. #PrecisionMedicine #pathology
Isabl Inc. retweeted
Congrats to our colleague Dr. Majd Al Assaad (@MajdAssaad) on a great presentation of his research with @JyothiManohar23, Michael Sigouros, Drs. David Wilkes, @asbonerw, @ElementoLab, David J. Pisapia, and Juan Miguel Mosquera; with @isabl_io @WCMCPathology @TheUSCAP #USCAP2022














